HIV-Associated Nephropathy: Clinical Presentation, Pathology, and Epidemiology in the Era of Antiretroviral Therapy

Seminars in Nephrology

Volumn 28, Issue 6, 2008, Pages 513-522

  Wyatt, Christina M ^a   Klotman, Paul E ^a   D'Agati, Vivette D ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

focal segmental glomerulosclerosis; HIV; HIV associated nephropathy; kidney

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KI 67 ANTIGEN; VPR PROTEIN; ZINC FINGER PROTEIN;

ADJUVANT THERAPY; ARTICLE; CD4 CD8 RATIO; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DIABETIC NEPHROPATHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ELECTRON MICROSCOPY; ERYTHROPHAGOCYTOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNE COMPLEX NEPHRITIS; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRANSGENE; VIRUS ETIOLOGY; VIRUS PATHOGENESIS;

AIDS-ASSOCIATED NEPHROPATHY; ANTI-RETROVIRAL AGENTS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY; MORBIDITY; UNITED STATES;

EID: 55649092856     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2008.08.005     Document Type: Article

References (63)

1. Rao T.K., Filippone E.J., Nicastri A.D., Landesman S.H., Frank E., Chen C.K., et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310 (1984) 669-673
2. Pardo V., Aldana M., Colton R.M., Fischl M.A., Jaffe D., Moskowitz L., et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101 (1984) 429-434
3. Gardenswartz M.H., Lerner C.W., Seligson G.R., Zabetakis P.M., Rotterdam H., Tapper M.L., et al. Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 21 (1984) 197-204
4. Ross M.J., and Klotman P.E. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 13 (2002) 2997-3004
5. U.S. Renal Data System. USRDS 2007 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States (2007). http://www.usrds.org/
6. Cantor E.S., Kimmel P.L., and Bosch J.P. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151 (1991) 125-128
7. Winston J.A., Bruggeman L.A., Ross M.D., Jacobson J., Ross L., D'Agati V.D., et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344 (2001) 1979-1984
8. Atta M.G., Choi M.J., Longenecker J.C., Haymart M., Wu J., Nagajothi N., et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am J Med 118 (2005) 1288
9. Atta M.G., Longenecker J.C., Fine D.M., Nagajothi N., Grover D.S., Wu J., et al. Sonography as a predictor of human immunodeficiency virus-associated nephropathy. J Ultrasound Med 23 (2004) 603-610 612-3
10. D'Agati V., and Appel G.B. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 18 (1998) 406-421
11. Cohen A.H., and Nast C.C. HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1 (1988) 87-97
12. D'Agati V., Suh J.I., Carbone L., Cheng J.T., and Appel G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 35 (1989) 1358-1370
13. Strauss J., Abitbol C., Zilleruelo G., Scott G., Paredes A., Malaga S., et al. Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 321 (1989) 625-630
14. Cohen A.H., and Nast C.C. Renal injury associated with human immunodeficiency virus infection. In: Jennette C.J., Olson J.L., Schwartz M.M., and Silva F.G. (Eds). Heptinstall's pathology of the kidney (2007), Lippincott Williams & Wilkins, Philadelphia
15. D'Agati V.D., Fogo A.B., Bruijn J.A., and Jennette J.C. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43 (2004) 368-382
16. Rosenstiel P., Letourneau T.G.A., Chan J.C., Husain M., D'Agati V., Klotman M.E., et al. HIV-1 vpr impairs cytokinesis in human proximal tubule cells leading to multinucleation and hypertrophy: implications for HIVAN pathogenesis. Kidney Int (2008) In press
17. Rey L., Viciana A., and Ruiz P. Immunopathological characteristics of in situ T-cell subpopulations in human immunodeficiency virus-associated nephropathy. Hum Pathol 26 (1995) 408-415
18. Chander P., Soni A., Suri A., Bhagwat R., Yoo J., and Treser G. Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 126 (1987) 513-526
19. Nagata M., Nakayama K., Terada Y., Hoshi S., and Watanabe T. Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 153 (1998) 1511-1520
20. Pavenstadt H., Kriz W., and Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83 (2003) 253-307
21. Barisoni L., Kriz W., Mundel P., and D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10 (1999) 51-61
22. Shankland S.J., Eitner F., Hudkins K.L., Goodpaster T., D'Agati V., and Alpers C.E. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 58 (2000) 674-683
23. Barisoni L., Mokrzycki M., Sablay L., Nagata M., Yamase H., and Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58 (2000) 137-143
24. Barisoni L., Bruggeman L.A., Mundel P., D'Agati V.D., and Klotman P.E. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58 (2000) 173-181
25. Gherardi D., D'Agati V., Chu T.H., Barnett A., Gianella-Borradori A., Gelman I.H., et al. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 15 (2004) 1212-1222
26. Dijkman H.B., Weening J.J., Smeets B., Verrijp K.C., van Kuppevelt T.H., Assmann K.K., et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 70 (2006) 338-344
27. Bariety J., Mandet C., Hill G.S., and Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 17 (2006) 2770-2780
28. Husain M., D'Agati V.D., He J.C., Klotman M.E., and Klotman P.E. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 19 (2005) 1975-1980
29. Valeri A., Barisoni L., Appel G.B., Seigle R., and D'Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 50 (1996) 1734-1746
30. Moudgil A., Nast C.C., Bagga A., Wei L., Nurmamet A., Cohen A.H., et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59 (2001) 2126-2133
31. Li R.M., Branton M.H., Tanawattanacharoen S., Falk R.A., Jennette J.C., and Kopp J.B. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 13 (2002) 2320-2330
32. Tomlinson L., Boriskin Y., McPhee I., Holwill S., and Rice P. Acute cytomegalovirus infection complicated by collapsing glomerulopathy. Nephrol Dial Transplant 18 (2003) 187-189
33. Thaunat O., Delahousse M., Fakhouri F., Martinez F., Stephan J.L., Noel L.H., et al. Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int 69 (2006) 1892-1898
34. Shah M., Jenis E.H., Mookerjee B.K., Schriber J.R., Baer M.R., Herzig G.P., et al. Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer 83 (1998) 1938-1946
35. Markowitz G.S., Appel G.B., Fine P.L., Fenves A.Z., Loon N.R., Jagannath S., et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12 (2001) 1164-1172
36. Greenberg A., Bastacky S.I., Iqbal A., Borochovitz D., and Johnson J.P. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am J Kidney Dis 29 (1997) 334-344
37. Avila-Casado M.C., Vargas-Alarcon G., Soto M.E., Hernandez G., Reyes P.A., and Herrera-Acosta J. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features. Kidney Int 63 (2003) 233-239
38. Nadasdy T., Allen C., and Zand M.S. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes. Hum Pathol 33 (2002) 437-441
39. Berliner A.R., Fine D.M., Lucas G.M., Rahman M.H., Racusen L.C., Scheel P.J., et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28 (2008) 478-486
40. Fine D.M., Perazella M.A., Lucas G.M., and Atta M.G. Kidney biopsy in HIV: beyond HIV-associated nephropathy. Am J Kidney Dis 51 (2008) 504-514
41. D'Agati V., and Appel G.B. HIV infection and the kidney. J Am Soc Nephrol 8 (1997) 138-152
42. Ahuja T.S., Borucki M., Funtanilla M., Shahinian V., Hollander M., and Rajaraman S. Is the prevalence of HIV-associated nephropathy decreasing?. Am J Nephrol 19 (1999) 655-659
43. Lucas G.M., Eustace J.A., Sozio S., Mentari E.K., Appiah K.A., and Moore R.D. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 18 (2004) 541-546
44. Szczech L.A., Gupta S.K., Habash R., Guasch A., Kalayjian R., Appel R., et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66 (2004) 1145-1152
45. Atta M.G., Gallant J.E., Rahman M.H., Nagajothi N., Racusen L.C., Scheel P.J., et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 21 (2006) 2809-2813
46. Wali R.K., Drachenberg C.I., Papadimitriou J.C., Keay S., and Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy [letter]. Lancet 352 (1998) 783-784
47. Gupta S.K., Eustace J.A., Winston J.A., Boydstun I.I., Ahuja T.S., Rodriguez R.A., et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40 (2005) 1559-1585
48. Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services. December 1, 2007; 1-136. [cited 2007 Dec 30]. Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
49. Wei A., Burns G.C., Williams B.A., Mohammed N.B., Visintainer P., and Sivak S.L. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int 64 (2003) 1462-1471
50. Smith M.C., Austen J.L., Carey J.T., Emancipator S.N., Herbener T., Gripshover B., et al. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101 (1996) 41-48
51. Eustace J.A., Nuermberger E., Choi M., Scheel Jr. P.J., Moore R., and Briggs W.A. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 58 (2000) 1253-1260
52. Ross M.J., Fan C., Ross M.D., Chu T.H., Shi Y., Kaufman L., et al. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 42 (2006) 1-11
53. Ahuja T.S., Collinge N., Grady J., and Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol 13 (2002) 1889-1893
54. Ahuja T.S., Collinge N., Grady J., and Khan S. Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?. Am J Kidney Dis 41 (2003) 1060-1064
55. Wyatt C.M., and Murphy B. Kidney transplantation in HIV-infected patients. Semin Dial 18 (2005) 495-498
56. Schwartz E.J., Szczech L.A., Ross M.J., Klotman M.E., Winston J.A., and Klotman P.E. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 16 (2005) 2412-2420
57. Lopes G.S., Marques L.P., Rioja L.S., Basilio-de-Oliveira C.A., Oliveira A.V., Nery A.C., et al. Glomerular disease and human immunodeficiency virus infection in Brazil. Am J Nephrol 12 (1992) 281-287
58. Laradi A., Mallet A., Beaufils H., Allouache M., and Martinez F. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol 9 (1998) 2327-2335
59. Wools-Kaloustian K., Gupta S.K., Muloma E., Owino-Ong'or W., Sidle J., Aubrey R.W., et al. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant 22 (2007) 2208-2212
60. Emem C.P., Arogundade F., Sanusi A., Adelusola K., Wokoma F., and Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant 23 (2008) 741-746
61. Han T.M., Naicker S., Ramdial P.K., and Assounga A.G. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69 (2006) 2243-2250
62. Gerntholtz T.E., Goetsch S.J., and Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 69 (2006) 1885-1891
63. Arogundade F.A., and Barsoum R.S. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 51 (2008) 515-523